Arkolith/Insider Trading/AUGX/Form 4

Faulkner Robert C.

DirectorAugmedix, Inc. (AUGX) · full profile →Form 4 · filed Oct 4, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 2, 2024Disposed to issuer(D)41K$2.35$97K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-106311) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML